“Bringing the world into focus
through the lens of Scripture”









K-House Africa


Banking Details



 Africa news





The Rise Of Islam












Global Government
















 Kings High Way Briefing Packs







 In The News provided by Koinonia House

Monitor The Strategic Trends

Biotech & Global Pestilence Introduction:


The threat of germ warfare has brought to the forefront long-forgotten diseases like plague, anthrax, and smallpox. Recent television news programs have highlighted secret projects in the former Soviet Union to develop antibiotic-resistant strains of genetically engineered viruses and bacteria.





Human Nature


Ron Matsen





About available formats


What does it mean to be human? Philosophers, theologians, sociologists and psychologists have attempted to understand the nature of mankind for ages. Their conclusions often contradict each other which lead to confusion rather than clarification. Clearly Man is a very complicated social being. The Bible tells us that man is “fearfully and wonderfully made.”
  • How do we understand our makeup and does it make a difference?
  • What is the meaning of being “created in the image of God?”
  • What causes our natural responses and can we change this behaviour?

Join Ron Matsen from the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of our “Human Nature” and gives insight into the architecture and accountability of all mankind.

This briefing pack contains approx. 2 hours of teaching.

  • DVD discs
  • M4A files
  • PDF Notes file

CANCER  Awareness



Dedicated Page




Price R 179





Beginning of Wisdom



 Dr. Chuck Missler

“The fear of God is the beginning of wisdom.” Proverbs 9:10

But how do we balance the awesome majesty due to the Creator and Ruler of the universe with the gracious family intimacy that is now available to us through the completed work of Christ?

What does His Holiness demand of us, personally?

What are the hazards of failing to render the Almighty His due, while availing ourselves the riches committed to us of the precious promises in His Word?

How do we deal with these paramount issues facing us daily in practical challenges?

Chuck Missler grapples with these wildly misunderstood tensions with down-to-earth frankness and Biblically-based candor.




Price R 179.00



The Gospel: The Message of Reconciliation


by Ron Matsen 




Price R 179.00





One of the last instructions given by Jesus to the Church was, “Go into all the world and preach the gospel.” (Mark 16:15)

The fact is most Christians don’t know how to share their faith effectively. Sadly, many of the people they know in the world today are wandering around, lost and without hope, having never heard the wonderful Message of Reconciliation.

How would you answer the question, “What must I do to be saved?”

What are the essential facts, demands and promises of the Gospel?

Why are we told to evangelize?

Join Ron Matsen in the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of “The Gospel – The Message of Reconciliation” and gives practical insight into how to share the essential doctrines of salvation.

This briefing pack contains 2 hours of teaching

© Copyright 2013



City Press




Disaster Management News from TerraDaily.com


Earth News, Earth Science, Energy Technology, Environment News
















Koinonia Institute presents its 2014 Strategic Perspectives IX Conference in Coeur d' Alene, Idaho on DVD, intel and insight to understand the times.

DVD Set - 10 discs
Run time approximately 21 Hours
Dr. Chuck Missler: The Spiritual Entrepreneur
L.A. Marzulli: On the Trail of the Nephilim
Bill Salus: Nuclear Showdown in Iran: Revealing the Ancient Prophecy of Elam
Mark Biltz: The Blood Moons
Joseph Farah: ISIS SHMISIS: God's Mideast Peace Plan
Bob Cornuke: Amazing New Discoveries that Change Everything about the Location of Solomon's Temple
Louis Powell: China - The Sleeping Dragon
Ron Matsen: The Re-emergence of Assyria

Also featuring: Trevor MacDuff, Chris Corlett, Jeff Altus, Gordon McDonald, William Welty, Avi Lipkin, Dan Stolebarger, Kings Highway/Debbie Holland, Steve Elwart, John Loeffler, and Jay Seegert


Price R799.00



Diseases/Conditions News Headlines - Yahoo! News



Family of Frank Gifford says late NFL star suffered from brain disease

‎25 ‎November ‎2015, ‏‎11:15:13 PMGo to full article
By Steve Ginsburg WASHINGTON (Reuters) - The family of Frank Gifford said on Wednesday the late NFL Hall of Famer suffered from the degenerative brain disease CTE and that his brain had been donated to help researchers explore the link between football and traumatic head injuries. Gifford, an eight-time Pro Bowl selection for the New York Giants, died of natural causes in August at the age of 84. Gifford's' survivors, including his wife, "Today" show host Kathie Lee Gifford, said in a statement released by NBC that pathologists confirmed their suspicions that he was suffering from chronic traumatic encephalopathy (CTE), a progressive degenerative brain disease linked to repeated head trauma.

For women with diabetes, air pollution has higher heart risks

‎25 ‎November ‎2015, ‏‎11:12:30 PMGo to full article
By Kathryn Doyle (Reuters Health) - Particle pollution like soot is a known health hazard and linked to the risk of heart disease and stroke, but women with diabetes are even more vulnerable than most people, according to a new U.S. study. “There is a convincing literature that long-term air pollution is associated with a higher risk of cardiovascular disease,” said lead author Jaime E. Hart of Brigham and Women’s Hospital and Harvard Medical School in Boston, adding, “a number of studies of short-term air pollution exposures have suggested that individuals with diabetes are at higher risk of cardiovascular disease.” The researchers studied 114,537 women in the decades-long Nurses’ Health Study for whom there was data on pollution exposure and health outcomes.

France detects first bird flu outbreak in eight years

‎25 ‎November ‎2015, ‏‎07:39:10 PMGo to full article
By Sybille de La Hamaide and Gus Trompiz PARIS (Reuters) - France, the European Union's biggest agricultural producer, reported its first outbreak of the deadly H5N1 bird flu virus in eight years after detecting it in a backyard in a southwestern region home to many foie gras and poultry producers. The highly pathogenic H5N1 virus killed 22 chickens out of 32 kept in a family backyard at Biras in the Perigord region, officials said. Ministers asked France's health and safety agency to evaluate the strain's degree of danger to humans, Agriculture Minister Stephane Le Foll told reporters, insisting there was no risk of transmission by eating food.

EU approves Roche's Cotellic in combo therapy against skin cancer

‎25 ‎November ‎2015, ‏‎05:05:26 PMGo to full article
Swiss drugmaker Roche's logo is seen at their headquarters in Basel, SwitzerlandThe European Union gave its green light to Roche's Cotellic for use in combination with the drug Zelboraf against advanced melanoma, the company said on Wednesday. Roche is counting on Cotellic to help it revive flagging sales of five-year-old Zelboraf, which dropped 25 percent during the first nine months of 2015. It has been under intense pressure from rivals' drugs as the standard of care moves to combination therapy.

FDA approves Lilly's lung cancer drug

‎24 ‎November ‎2015, ‏‎08:11:38 PMGo to full article
(Reuters) - The U.S. Food and Drug Administration said it had approved Eli Lilly & Co's Portrazza, in combination with two forms of chemotherapy, to treat patients with a type of lung cancer. The FDA's approval on Tuesday comes about four months after an advisory panel to the agency recommended the drug be cleared for sale along with the warnings. Lung cancer is the leading cause of cancer death in the United States, with about 221,000 new diagnoses and 158,000 deaths so far in 2015.

Childhood cancer survivors may face physical, mental health issues

‎24 ‎November ‎2015, ‏‎07:24:37 PMGo to full article
By Lisa Rapaport (Reuters Health) - Childhood cancer survivors may face a higher than average risk of hospitalizations and cognitive challenges later in life, two recent studies in JAMA Oncology suggest. One study in Denmark tracked more than 33,000 people who’d had cancer as adolescents or young adults, following more than half of them for at least 14 years. During the study, these survivors were 38 percent more likely to be hospitalized than 228,000 similar people who didn’t have a history of cancer.

Vaccinate Yourself Against 5 Common Flu Myths

‎24 ‎November ‎2015, ‏‎05:01:58 PMGo to full article
Vaccinate Yourself Against 5 Common Flu MythsIt's flu season again. And now, along with the barrage of helpful flu shot reminders, comes the annual outbreak of myths about the flu.First, here are some basic facts. Influenza (also known as the "flu") is a contagious respiratory illness caused by influenza viruses, and is different from the common cold. According to the Centers for Disease...

Hong Kong reports bird flu in wild bird, no spread evident: OIE

‎24 ‎November ‎2015, ‏‎04:47:37 PMGo to full article
Hong Kong reported that the highly pathogenic H5N6 bird flu virus had been detected in a wild bird last week but said no spread of the disease was evident, the World Organisation for Animal Health (OIE) said on Tuesday. The outbreak is considered as resolved, the department in charge of agriculture for the Hong Kong Special Administrative Region said in a report posted on the OIE website.

5 Lies Ruining Your Mental Health

‎24 ‎November ‎2015, ‏‎03:35:33 PMGo to full article
5 Lies Ruining Your Mental HealthOne in five Americans experience a mental health problem in any given year. Yet many people suffer with their symptoms in silence. The stigma that continues to surround mental health problems prevents individuals from getting the help they need.It's a common problem I've seen in my therapy office. People often waited years to seek help. Even...

FDA approves expanded use of Bristol-Myers' skin cancer drug

‎24 ‎November ‎2015, ‏‎02:33:53 PMGo to full article
(Reuters) - Bristol-Myers Squibb Co said the U.S. Food and Drug Administration had approved the expanded use of its cancer drug, Opdivo, to treat an additional form of advanced skin cancer. The company said on Tuesday the approval allows for the drug's use in patients with a previously untreated, advanced form of melanoma and is based on data from a late-stage study comparing the drug with chemotherapy. Opdivo, already in use in patients with forms of lung cancer and with advanced melanoma who have received treatment, belongs to a promising new class of drugs designed to help the body's immune system fight cancer by blocking a protein called programmed death receptor (PD-1).

FDA approves Bristol-Myers drug for new use in kidney cancer

‎23 ‎November ‎2015, ‏‎11:38:00 PMGo to full article
WASHINGTON (AP) — Federal health regulators have expanded approval of a cancer drug from Bristol-Myers Squibb to treat an advanced form of kidney cancer.

Expensive new Hep C drugs may be cost-effective even for early disease

‎23 ‎November ‎2015, ‏‎11:33:13 PMGo to full article
By Andrew M. Seaman (Reuters Health) - Treating hepatitis C with expensive new medicines at the earliest signs of liver damage improves patients' health and is also cost-effective, a new computer simulation suggests. "Going into this, I expected to find it did make sense to wait until there was a limited amount of liver disease, but what we found to our surprise is that it makes sense to start treatment at the earliest change in the liver," said senior author Dr. James Kahn, of the University of California, San Francisco. Hepatitis C virus (HCV) is spread by blood.

Using new gene drive to create malaria-resistant mosquitoes

‎23 ‎November ‎2015, ‏‎10:19:30 PMGo to full article
This photo provided by the Centers for Disease Control and Prevention (CDC ) shows a feeding female Anopheles stephensi mosquito crouching forward and downward on her forelegs on a human skin surface, in the process of obtaining its blood meal through its sharp, needle-like labrum, which it had inserted into its human host. California researchers hatch malaria-resistant mosquitoes and use a groundbreaking technology to ensure the insects pass on the protective gene as they reproduce. It has implications far beyond fighting malaria. (James Gathany/CDC via AP)WASHINGTON (AP) — California researchers hatched some malaria-resistant mosquitoes and then gave evolution a shove — using a groundbreaking technology to ensure the insects pass on that protective gene as they reproduce, with implications far beyond the promise of fighting malaria.

Scientists create mosquito strain with malaria-blocking genes

‎23 ‎November ‎2015, ‏‎10:05:48 PMGo to full article
An Anopheles stephensi mosquito obtains a blood meal from a human host through its pointed proboscis in this handout photoBy Will Dunham WASHINGTON (Reuters) - Scientists aiming to take the bite out of malaria have produced a strain of mosquitoes carrying genes that block its transmission, with the idea that they could breed with other members of their species in the wild and produce offspring that cannot spread the disease. The researchers said on Monday they used gene-editing, a genetic engineering technique in which DNA can be inserted, replaced or deleted from a genome, on a species called Anopheles stephensi that spreads malaria in urban India. Malaria is caused by parasites transmitted to people through the bites of infected female mosquitoes.

UK bacon and sausages sales hit by cancer link - report

‎23 ‎November ‎2015, ‏‎03:51:50 PMGo to full article
Vendor sells sausages prepared at a local sausage shop of the "Russia" collective farm in the settlement of GrigoropolisskayaSales of pre-packed sausages and bacon fell sharply at Britain's top grocers in the weeks following publication of a World Health Organisation (WHO) report, which said eating processed meat can cause bowel cancer, data published on Monday showed. The France-based International Agency for Research on Cancer (IARC), part of the WHO, last month put processed meat in its Group 1 list, which includes tobacco, asbestos and diesel fumes, for which there is "sufficient evidence" of cancer links. Researcher IRI measured sales of bacon and sausages at Britain's major grocery stores in the week ended Oct. 31 of the IARC announcement, and the following week ended Nov. 7, estimating the value of sales declines at about 3 million pounds ($4.5 million) over the two weeks.

1 In 3 Healthy Adults Will Develop Diabetes Over Their Lifetime

‎22 ‎November ‎2015, ‏‎04:20:44 PMGo to full article
1 In 3 Healthy Adults Will Develop Diabetes Over Their Lifetime(Reuters Health) - Almost half of 45-year-olds will develop so-called prediabetes, an elevated blood sugar level that often precedes diabetes, according to a large study from The Netherlands using population estimates.Prediabetes, sometimes called impaired glucose metabolism, has no clear symptoms, but people with higher than normal blood sugar...

Novartis gets FDA approval for skin cancer drug combination

‎21 ‎November ‎2015, ‏‎01:38:15 AMGo to full article
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in Basel(Reuters) - Novartis AG said on Friday it received the U.S. Food and Drug Administration's regular approval for a drug combination to treat an aggressive form of skin cancer. The FDA approved Tafinlar and Mekinist for treatment of metastatic melanoma based on two years overall survival in patients, the company said. The combination was initially approved based on mid-stage data through the FDA's accelerated approval program, but the approval was contingent on data from late-stage trial.

NovoCure's cancer therapy effective in late-stage study

‎21 ‎November ‎2015, ‏‎12:31:19 AMGo to full article
(Reuters) - NovoCure Ltd said its lead cancer therapy improved survival rate in brain cancer patients in combination with Avastin in a late-stage study, sending its shares up 23 percent in extended trading. NovoCure's therapy, Optune, which was evaluated in combination with Roche Holding AG's cancer drug, reduced the risk of death by 39 percent in patients, compared with patients treated with Avastin alone, Novocure said in a statement on Friday. Optune is an FDA-approved device for use in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain tumor in which 90 percent of adult patients die within 24 months after the diagnosis.

Smokeless tobacco users exposed to more nicotine, cancer-causing chemical

‎21 ‎November ‎2015, ‏‎12:26:00 AMGo to full article
By Andrew M. Seaman (Reuters Health) - Compared to cigarette smokers, users of smokeless tobacco are exposed to equal or higher levels of nicotine and NNK, a cancer-causing chemical in tobacco products, according to a study from the U.S. government. More research is needed on the toxic components of smokeless tobacco products and the health of people who use them, write the researchers from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention. "It’s not uncommon for people to use smokeless tobacco as an alternative to cigarettes in an attempt to wean themselves off smoking," said Dr. Frank Leone, who is director of the University of Pennsylvania's Comprehensive Smoking Treatment Program in Philadelphia.

Celldex vaccine improves long-term brain cancer survival in study

‎20 ‎November ‎2015, ‏‎11:08:32 PMGo to full article
(Reuters) - New data from a midstage trial show that Celldex Therapeutics Inc's experimental brain cancer vaccine, combined with standard therapy, continues to improve chances of survival for patients with recurrent cancer. The updated results sent shares of Celldex up $1.74, or 12 percent, to $16.23 on the Nasdaq. The therapy, designed to enlist the body's immune system to fight glioblastoma multiforme (GBM), showed that 25 percent of patients given Celldex's Rintega along with Roche Holding AG's Avastin were alive after two years, compared with no survivors in the group of patients given only Avastin.

Air pollution linked to asthma in children and teens

‎20 ‎November ‎2015, ‏‎07:14:12 PMGo to full article
Builders at work on hazy day in Kuala LumpurBy Lisa Rapaport (Reuters Health) - Exposure to air pollution early in life may contribute to the development of asthma in childhood and adolescence, a European study suggests. Researchers followed more than 14,000 children from birth through ages 14 to 16 and found those born in communities with more polluted air were more likely to develop asthma than other kids, particularly after age 4. While previous research has linked asthma to air pollution exposure in early childhood, the current study offers new evidence that this connection extends into adolescence, said lead author Dr. Ulrike Gehring, a researcher at Utrecht University in The Netherlands.

Pecking Pigeons Detect Breast Cancer

‎20 ‎November ‎2015, ‏‎06:21:30 PMGo to full article
Pecking Pigeons Detect Breast CancerPigeons are no bird brains.These animals could help scientists make big advances in the world of breast cancer research, according to a peer-reviewed research article published this week in PLOS One titled "Pigeons (Columba livia) as Trainable Observers of Pathology and Radiology Breast Cancer Images." Study leaders trained 16 birds to...

EU endorses copy of Enbrel arthritis drug from Samsung, Biogen

‎20 ‎November ‎2015, ‏‎02:42:12 PMGo to full article
By Ben Hirschler LONDON (Reuters) - A copy of the blockbuster biotech drug Enbrel was recommended for approval in Europe on Friday, making it the second so-called biosimilar antibody medicine to win such a green light from the continent's regulators. The European Medicines Agency (EMA) said its experts backed the use of South Korean company Samsung Bioepis's version of etanercept, as Enbrel is known scientifically, for rheumatoid arthritis and other autoimmune diseases. The drug will be sold in Europe by U.S. biotechnology group Biogen.

Social and economic factors tied to pancreatic cancer surgery, survival

‎20 ‎November ‎2015, ‏‎02:18:43 AMGo to full article
By Andrew M. Seaman (Reuters Health) - Social and economic factors may influence who is most likely to get surgery for early-stage pancreas cancer, a new U.S. study suggests, and eliminating these gaps could improve outcomes, the authors say. Factors such as race, marital status, insurance coverage and region were linked to the odds someone with pancreas cancer would get surgery to remove the tumor, as well as how advanced their tumor was when diagnosed. "It likely indicates that efforts to improve outcomes for pancreas cancer are best aimed at eliminating disparities in access and utilization of resection for early-stage pancreas cancer," said senior author Dr. Jason Gold, of Harvard Medical School and the VA Boston Healthcare System.

Depression linked to erectile dysfunction in sleep apnea patients

‎19 ‎November ‎2015, ‏‎10:03:22 PMGo to full article
By Lisa Rapaport (Reuters Health) - Depression and low quality of life may contribute to erectile dysfunction in men with sleep apnea, a Korean study suggests. Sleep apnea, a common disorder that leads to disrupted breathing or shallow breaths during slumber, has long been tied sexual health problems, researchers note in the Journal of Sexual Medicine. “Although the severity of obstructive sleep apnea is one of the risk factors for erectile dysfunction, the depression is likely to have a bigger impact,” said senior study author Hyun-Woo Shin of Seoul National University.

Light therapy may ease depression, not just winter blues

‎19 ‎November ‎2015, ‏‎09:16:00 PMGo to full article
By Lisa Rapaport (Reuters Health) - Light therapy, long used to help improve mood in people who get the blues when days are darker and shorter, can also treat non-seasonal depression, a small Canadian study suggests. Depression is one of the most common mental health disorders and a leading cause of disability and reduced quality of life worldwide, the researchers note in JAMA Psychiatry. While many people with depression may be helped by medication or psychotherapy, these options don’t work for everybody and some patients don’t stick with treatment due to side effects or challenges related to access or affordability.

Many Children With Cancer Were Born With Genes That Increase Risk

‎19 ‎November ‎2015, ‏‎05:48:40 PMGo to full article
Many Children With Cancer Were Born With Genes That Increase RiskGene sequencing of more than 1,000 children and adolescents diagnosed with cancer found that as many as 8.5 percent were born with genes that increase their risk of developing cancer, U.S. researchers said on Wednesday.Of the children with cancer risk genes, only 40 percent came from families with a known history of cancer, suggesting that...

Working out could help ward off prostate cancer in men over 60

‎19 ‎November ‎2015, ‏‎04:01:42 PMGo to full article
Working out could help ward off prostate cancer in men over 60Researchers from the University of California in San Francisco looked at data from two US studies which together tracked more than 62,000 men for a period of 24-28 years. After calculating the number of men who went on to develop lethal prostate cancer, and studying the lifestyle factors in the two groups, the team estimated that in the United States 47% of lethal prostate cancer cases could be prevented if men over 60 followed five or more of these healthy habits. Looking at these healthy lifestyle factors on their own, consuming at least seven servings of tomatoes per week could cut the risk by 15%, consuming at least one serving of fatty fish per week by 17%, and reducing intake of processed meats would cut the risk by 12%.

Servier and Pfizer get rights to Cellectis cancer cell therapy

‎19 ‎November ‎2015, ‏‎10:09:54 AMGo to full article
(Reuters) - U.S. drugmaker Pfizer and France's Servier have snapped up rights to a promising cell therapy developed by French biotech firm Cellectis to fight blood cancers. The so-called CAR T cell technology used by Cellectis involves reprogramming immune system cells to hunt out cancer. Cellectis said on Thursday that Servier had exercised an option to acquire the exclusive worldwide rights to UCART19, which is about to enter initial Phase I clinical tests, and Pfizer would work with Servier on the drug's development.

Disease-free 'devils' transported back to Australian island home

‎19 ‎November ‎2015, ‏‎08:59:00 AMGo to full article
Devil Ark operations manager Drinkwater inspects Irene, a Tasmanian Devil as she is prepared as part of the first shipment of healthy and genetically diverse devils to Tasmania, at the Devil Ark sanctuary in Barrington Tops, AustraliaThe largest group so far of disease-free Tasmanian devils has been released in the wild, as part of plans to save the carnivorous marsupials from a cancer threatening them with extinction. The Tasmanian devil population has plummeted to around 10,000 from an estimated 250,000 before 1996, when Devil Facial Tumor Disease was first discovered. "Tasmanian Devils in the wild have been absolutely decimated by this disease," Mike Drinkwater, operations manager at the Devil Ark recovery program told Reuters.

Many children with cancer were born at risk: U.S. study

‎19 ‎November ‎2015, ‏‎01:13:02 AMGo to full article
Gene sequencing of more than 1,000 children and adolescents diagnosed with cancer found that as many as 8.5 percent were born with genes that increase their risk of developing cancer, U.S. researchers said on Wednesday. Of the children with cancer risk genes, only 40 percent came from families with a known history of cancer, suggesting that family history was not a strong predictor of childhood cancers, the researchers reported in the New England Journal of Medicine. "This paper marks an important turning point in our understanding of pediatric cancer risk and will likely change how patients are evaluated,” Dr. James Downing of St. Jude Children’s Research Hospital in Memphis, Tennessee, who worked on the study, said in a statement.

Pigeons tend to land on the right spot when looking for breast cancer

‎18 ‎November ‎2015, ‏‎10:53:28 PMGo to full article
By Andrew M. Seaman (Reuters Health) - - Years of schooling and training are needed to teach pathologists and radiologists to spot cancer on medical images, but a new study finds that pigeons can be about as accurate as these professionals, with the help of a few food pellets. People don't have to worry about bird brains diagnosing their cancers any time soon, but the study's lead researcher says pigeons may have a future standing in for pathologists and radiologists in the kinds of mind-numbing studies of new technologies that involve examining thousands of images. "If you showed me 10 images, I’d be ok," said Dr. Richard Levenson, of the University of California Davis Medical Center in Sacramento.



Europe could recommend second biosimilar arthritis drug this week

‎18 ‎November ‎2015, ‏‎02:13:02 PMGo to full article
By Ben Hirschler LONDON (Reuters) - Europe could soon gain a second biosimilar antibody drug for rheumatoid arthritis and other autoimmune diseases, with regulators due to decide by Friday whether to recommend South Korean company Samsung Bioepis's copy of Enbrel. Biosimilar copies of expensive biotech drugs are gaining momentum in Europe, which has been faster to adopt their use than the United States, and their potential to take business from companies making the original products is being monitored closely by investors. AbbVie, which sells the market-leading rheumatoid arthritis drug Humira, is viewed as being particularly at risk.

Swaziland makes progress in quest to eliminate malaria

‎18 ‎November ‎2015, ‏‎01:51:56 PMGo to full article
JOHANNESBURG (AP) — An international health expert says Swaziland could eliminate malaria by the end of 2016 or in early 2017, likely making it the first mainland country in sub-Saharan Africa to get rid of the deadly disease.

Prostate Cancer Screening Down in U.S. Men

‎17 ‎November ‎2015, ‏‎11:08:51 PMGo to full article
Two studies published Tuesday in the Journal of the American Medical Association found that fewer men are being screened for prostate cancer, and fewer cases are being diagnosed nationwide. Whether this is good or bad news is unclear - researchers stated that a reduction in excessive screening might be good, but it could also result in potentially deadly cases escaping detection. For decades, the prostate-specific antigen (PSA) test was recommended to test men age 50 and older for prostate cancer. However, in 2012 the U.S. Preventive Services Task Force issued a statement against PSA screening, citing evidence that screening might needlessly subject men with slow-growing tumors to surgery and other intensive treatments.

CDC: US sexually transmitted disease epidemic worsening

‎17 ‎November ‎2015, ‏‎07:25:31 PMGo to full article
CHICAGO (AP) — A U.S. sexually transmitted diseases epidemic is increasing and the most common infection, chlamydia, has risen to record levels, government officials say.

Less prostate cancer and screening seen after new guidance

‎17 ‎November ‎2015, ‏‎06:39:25 PMGo to full article
CHICAGO (AP) — Far fewer U.S. men are being diagnosed with early-stage prostate cancer and getting blood tests to detect the disease since an influential government-appointed panel recommended against routine screening of all men, an American Cancer Society study found.

Prostate cancer screening, early cases, in decline

‎17 ‎November ‎2015, ‏‎06:17:02 PMGo to full article
By Andrew M. Seaman (Reuters Health) - Use of a blood test to detect prostate cancer fell after a U.S. government-back panel advised against using it, researchers found. "I’m hoping that men are being allowed to make a choice and this decline reflects the fact that they prefer not to be screened," said study author Dr. Otis Brawley, who is chief medical officer for the American Cancer Society in Atlanta. Brawley told Reuters Health that 11 high-quality trials have examined the value of PSA screening, but only two found that the test saves lives.

Yoga can help prostate cancer sufferers deal with side effects

‎17 ‎November ‎2015, ‏‎01:45:53 PMGo to full article
Yoga can help prostate cancer sufferers deal with side effectsResearchers at the Perelman School of Medicine at the University of Pennsylvania have found that men undergoing radiation treatment for prostate cancer can stabilize and even decrease the side effects of the treatment with yoga. For the study, which was presented last month at the Society of Integrative Oncology's International Conference and which is expected to be published early next year, 68 eligible prostate cancer patients were invited to twice-weekly 75 minute yoga Eischens classes, with 66% willing to participate, and 40% completing the course. The effects of the yoga were measured by researchers in a series of questions on the patient's fatigue, erectile dysfunction, urinary incontinence, and general quality of life, all chosen for being common side effects among prostate cancer sufferers.

Roche breast cancer drug at center of UK pricing row

‎17 ‎November ‎2015, ‏‎02:06:15 AMGo to full article
By Ben Hirschler LONDON (Reuters) - A Roche drug that can prolong the lives of some women with advanced breast cancer has been plunged back into the center of a drug pricing row after Britain's health cost agency declared that it is still too expensive. The stand-off shows how the price of medicines is as pressing and emotive an issue in Europe as in the United States, where Democratic presidential candidate Hillary Clinton has promised to clamp down on alleged profiteering by the drug industry. Britain's National Institute for Health and Care Excellence (NICE) said on Tuesday that the price of Roche's Kadcyla remained too high to justify its use on the state-run National Health Service (NHS).

E-therapy may not help ease depression

‎17 ‎November ‎2015, ‏‎12:10:40 AMGo to full article
By Lisa Rapaport (Reuters Health) - Computer-assisted therapy may not be effective at easing depression in people who are already getting standard care such as counseling or medication, a U.K. study suggests. To assess the effectiveness of computer-assisted cognitive behavioral therapy, researchers randomly sorted about 700 patients into three groups. One group received only standard care, while the other groups were offered one of two computer therapy programs in addition to usual treatment.

Coffee-drinkers less likely to die from certain diseases

‎16 ‎November ‎2015, ‏‎11:21:20 PMGo to full article
Both caffeinated and decaffeinated coffee are shown to have benefits in a new US studyPeople who report drinking three to five cups of coffee per day are less likely to die prematurely from heart disease, suicide, diabetes or Parkinson's disease, US researchers said Monday. Both caffeinated and decaffeinated coffee were shown to have benefits, said the study by researchers at the Harvard University Chan School of Public Health published in the November 16 edition of the journal Circulation. The study compared people who don't drink coffee, or drank less than two cups daily, to those who reported drinking "moderate" amounts of coffee, or up to five cups daily.

Maryland governor says he is cancer free

‎16 ‎November ‎2015, ‏‎10:54:23 PMGo to full article
Maryland governor Larry Hogan speaks during a press conference in Baltimore MarylandHogan, 59, stunned the state in June only five months into office when he said he was diagnosed with stage III non-Hodgkin's lymphoma. Thank you for your support and keeping me #HoganStrong!" Hogan said in a Twitter feed. Hogan came to national attention in April when he sent National Guard troops into riot-hit Baltimore.

Clovis shares dive as FDA asks for more data on lung cancer drug

‎16 ‎November ‎2015, ‏‎08:53:20 PMGo to full article
Clovis Oncology Inc's shares plunged nearly 75 percent on Monday after U.S. heath regulators asked for more data on the company's lung cancer drug, potentially delaying its approval and giving a head start to AstraZeneca's rival treatment that was approved on Friday. Analysts had expected Clovis's drug, rociletinib, would be approved after a similar treatment from AstraZeneca Plc was approved on Friday, three months ahead of the expected date. "Clovis now appears to be at a big commercial disadvantage in both timing and label data," Mizuho analyst Eric Criscuolo wrote in a client note, slashing his price target on Clovis's stock to $35 from $114.

Cambodia reports outbreaks of H5N1 bird flu in northwest

‎16 ‎November ‎2015, ‏‎05:28:05 PMGo to full article
Cambodia reported two outbreaks of the highly pathogenic H5N1 bird flu virus among backyard duck flocks in the northwestern part of the country, the World Organisation for Animal Health (OIE) said on Monday. The outbreaks, which killed a total of 2,280 birds, were the first reported since March 2014, the OIE said. "After having been informed by the owners that their duck flocks were sick and were dying, the district and provincial veterinary services went there to investigate and took some samples (of sick ducks)," the Cambodian farm ministry said in a statement posted on the OIE website.

Genfit could bring NASH liver disease treatment to market in 2019

‎16 ‎November ‎2015, ‏‎12:50:27 PMGo to full article
French biopharmaceutical company Genfit said on Monday it is to launch a phase 3 study of its treatment for liver disease NASH by year-end as part of an accelerated approval procedure which could allow it to be brought to market in 2019. Genfit shares rose 5 pct to 42.71 euros on the news. There is currently no cure for Non-alcoholic Steatohepatitis (NASH), a degenerative liver disease caused by an excessively rich diet.

Diagnosed with cancer, Missouri football coach to resign after season

‎14 ‎November ‎2015, ‏‎01:24:42 AMGo to full article
NCAA Football: Mississippi State at MissouriGary Pinkel, the head coach of the University of Missouri's football team, said on Friday he has been diagnosed with non-Hodgkin lymphoma and will resign at the end of the year. Pinkel, who was diagnosed in May, said he informed his staff and team on Friday, the eve of the Tigers' game against Brigham Young University at Arrowhead Stadium in Kansas City, Missouri. Non-Hodgkin lymphoma is a cancer of the blood.

Wounded toll at 25,000 a month in Syria, medicines lacking, cholera feared: WHO

‎13 ‎November ‎2015, ‏‎08:10:54 PMGo to full article
A man with his clothes stained with blood walks at a site hit by what activists said was an airstrike by forces loyal to Syria's President al-Assad, in Kafruma village in the southern province of IdlibBy Stephanie Nebehay GENEVA (Reuters) - About 25,000 people are wounded each month in escalating warfare in Syria and it getting harder to deliver medical supplies for civilians trapped in areas held by Islamic State insurgents, the World Health Organization said on Friday. On top of that, there were concerns that deadly cholera could spread into Syria from Iraq.

AstraZeneca's potential $3 billion cancer pill wins early approval

‎13 ‎November ‎2015, ‏‎07:38:06 PMGo to full article
A man walks past a sign at an AstraZeneca site in MacclesfieldBy Ben Hirschler LONDON (Reuters) - A new lung cancer pill from AstraZeneca , designed for patients whose disease has worsened after treatment with other therapies, won early U.S. approval on Friday, in a boost for the British drugmaker. Tagrisso, also known as AZD9291, is one of several cancer medicines AstraZeneca hopes will rebuild its sales following patent losses on older drugs. Industry analysts are more cautious about sales in the next few years, with consensus expectations pointing to revenue of $1.1 billion in 2020, according to Thomson Reuters Cortellis.

1 In 5 NYC Residents Have A Mental Health Problem

‎13 ‎November ‎2015, ‏‎06:04:28 PMGo to full article
1 In 5 NYC Residents Have A Mental Health ProblemAt least one in five adult New Yorkers suffer from depression, substance abuse, suicidal thoughts or other psychological disorders every year, according to a report released on Thursday ahead of Mayor Bill de Blaiso's new mental-health initiative.New York City's Department of Health and Mental Hygiene expects to release the plan, known as NYC...

Nutrition Experts Answer the Most Common Questions About Diets and Eating Healthy

‎13 ‎November ‎2015, ‏‎05:40:17 PMGo to full article
Nutrition Experts Answer the Most Common Questions About Diets and Eating HealthyIf you're like most, sometimes figuring out what a healthy diet actually consists of might seem as confusing as trying to figure out how to put together a piece of Ikea furniture.Click Here to see the Complete List of Common Diet and Healthy Eating QuestionsFor the most part, basic nutrition is pretty straightforward, but the fact that we're...

European scientists say weedkiller glyphosate unlikely to cause cancer

‎13 ‎November ‎2015, ‏‎02:24:13 AMGo to full article
Monsanto's Roundup weedkiller atomizers are displayed for sale at a garden shop at Bonneuil-Sur-Marne near ParisBy Barbara Lewis BRUSSELS (Reuters) - Glyphosate is unlikely to cause cancer in humans, the European Food Safety Authority (EFSA) said on Thursday, and the agency proposed a higher limit on the daily amount of residue of the popular weed killer deemed safe if consumed. The EFSA advises EU policymakers and its conclusion could lead the 28-member European Union to renew approval for glyphosate, which was brought into use by Monsanto Co in the 1970s and is used in its top-selling product Roundup as well as in many other herbicides around the world. Environmental groups have been calling for a ban after the International Agency for Research on Cancer (IARC), part of the World Health Organization, said in March that glyphosate was "probably carcinogenic to humans".

New York City finds one in five adults has mental health problems

‎12 ‎November ‎2015, ‏‎11:50:27 PMGo to full article
A man crosses 6th Avenue as the sun sets in New YorkAt least one in five adult New Yorkers suffer from depression, substance abuse, suicidal thoughts or other psychological disorders every year, according to a report released on Thursday ahead of Mayor Bill de Blaiso's new mental-health initiative. New York City's Department of Health and Mental Hygiene expects to release the plan, known as NYC Thrive, by the end of next month. It is aimed at preventing and treating psychological disorders among the city's 8.4 million residents.

Choice in colon cancer screening linked to more regular testing

‎12 ‎November ‎2015, ‏‎10:35:17 PMGo to full article
By Lisa Rapaport (Reuters Health) - People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests. The other, a colonoscopy exam that snakes a tiny camera through the rectum to view the colon, searches for abnormal growths once a decade. About 1,000 patients were divided into three groups and randomly assigned to get either FOBT or colonoscopy, or given a choice between the two options.

Insomnia and the Performance of U.S. Workers

‎12 ‎November ‎2015, ‏‎06:51:21 PMGo to full article
Insomnia and the Performance of U.S. WorkersA 2011 Harvard Medical School study found that insomnia was significantly associated with lost work performance, and when projected onto the entire U.S. workforce, the study estimates that the lost performance due to insomnia costs businesses more than $63 billion per year. -- Arianna Huffington, Thrive Sleep Environment And Health Habits Play...

Older adults with diabetes may get exercise from video games

‎12 ‎November ‎2015, ‏‎06:46:49 PMGo to full article
By Kathryn Doyle (Reuters Health) - Middle aged and older people with type 2 diabetes may be able to meet activity guidelines by playing games on the Wii Fit Plus system, according to a small Swiss study. “Motivation to exercise is a major unsolved issue in patients with diabetes, especially type 2,” said senior author Dr. Arno Schmidt-Trucksass of the University of Basel. “Alternatives are urgently needed and enjoyable exercise while playing a game might be one.” The American Diabetes Association recommends that adults aim for at least 30 minutes a day, five days a week, of moderate to vigorous aerobic activities like brisk walking, tennis or hiking.

EU downplays cancer risk from weedkiller in win for Monsanto

‎12 ‎November ‎2015, ‏‎06:08:28 PMGo to full article
Glyphosate was first used as the active ingredient in the herbicide Roundup, manufactured by US agri-giant MonsantoA highly sensitive EU report on Thursday claimed one of the world's most popular weedkillers is "unlikely" to cause cancer, countering the UN and handing a victory to agri-business giant Monsanto. The report by the European Food Safety Agency concerned glyphosate, first used in the 1970s as the key ingredient in the Monsanto-made herbicide Roundup, and now made generically around the world. The agency advises the European Commission, the EU's executive arm, which must now use the report to decide jointly with member states whether to extend its approval for glyphosate for another 10 years.



European scientific advisers say glyphosate unlikely to cause cancer

‎12 ‎November ‎2015, ‏‎01:10:29 PMGo to full article
Monsanto's Roundup weedkiller atomizers are displayed for sale at a garden shop at Bonneuil-Sur-Marne near ParisThe European Food Safety Authority (EFSA) on Thursday said glyphosate, the active ingredient in Monsanto weedkiller Roundup, was unlikely to cause cancer in humans, but it proposed new controls on any residues in food. EFSA advises EU policymakers and its conclusion will be used by the European Commission to decide whether to extend the current approval period for glyphosate, which ends on Dec. 31. Environmental groups have been calling for a ban after the International Agency for Research on Cancer (IARC), part of the World Health Organization, said in March that glyphosate was "probably carcinogenic to humans".

Diabetes experts tell G20 to tax sugar to save lives and money

‎12 ‎November ‎2015, ‏‎02:08:36 AMGo to full article
Diabetes experts called on world leaders on Thursday to use sugar taxes to fight obesity, arguing such a move would save lives and slash healthcare budgets. Ahead of a meeting of G20 leaders this weekend, the International Diabetes Federation (IDF) wants the dual epidemics of obesity and diabetes to be placed on the global agenda alongside major geopolitical and financial issues. With one death every six seconds, diabetes is now a bigger killer than HIV, tuberculosis and malaria combined.

Women panic less when abnormal breast cells are not called cancer

‎11 ‎November ‎2015, ‏‎09:37:06 PMGo to full article
By Lisa Rapaport (Reuters Health) - Women may be less likely to panic or pursue aggressive treatment for a common, non-invasive breast tumor if doctors don’t use the word “cancer” to describe the abnormal cells, an Australian study suggests. Researchers focused on a pre-invasive malignancy of the breast known as ductal carcinoma in situ (DCIS) that is often detected by mammograms and treated with a mastectomy or with a lumpectomy paired with radiation. “There is growing evidence that we may be overtreating women with DCIS and that less aggressive approaches such as hormone-based therapy alone or active surveillance (also called watchful waiting) may be appropriate for some women with this diagnosis,” lead study author Kirsten McCaffery of the University of Sydney said by email.

Customized physical therapy may ease lower back pain

‎11 ‎November ‎2015, ‏‎08:43:53 PMGo to full article
By Lisa Rapaport (Reuters Health) - Customized physical therapy may provide more relief for lower back pain than general advice on the best ways to remain active, an Australian study suggests. Roughly half of them also got 10 treatment sessions of personalized physical therapy over 10 weeks. The physical therapy group had significantly greater reductions in activity limitations at 10, 26 and 52 weeks than the advice group and they also had less back pain at 5, 10 and 26 weeks.

Three Charts Show The Giant Disconnect Between Gun Deaths and Mental Health

‎11 ‎November ‎2015, ‏‎08:30:25 PMGo to full article
In the month since the Umpqua Community College shooting in Oregon — in which a 26-year-old man killed eight students and a professor — Congress has turned not to gun control, but mental health. Six days after the shooting, Rep. Martha McSally, R-Arizona, sponsored the Mental Health and Safe Communities Act, a bill first introduced by Sen. John Cornyn, R-Texas, in the Senate. Backed by the National Rifle Association, the law would “enhance the ability of local communities to identify and treat potentially dangerous, mentally-ill offenders,” as well as “help fix the existing background check system" according to Sen. Cornyn’s press release. The bill has gone on to receive bipartisan support, a rare feat in today’s polarized congressional climate.

Drug might help breast cancer patients avoid heart damage

‎11 ‎November ‎2015, ‏‎07:01:37 PMGo to full article
Cancer survivor Christine Ells embraces her twenty-month-old son Jameson after arriving home from work in Whitman, Mass., Monday, Nov. 9, 2015. Ells, 36, a teacher in the Boston suburb of Quincy, developed a heart rhythm problem from several drugs she was given to treat the breast cancer she was diagnosed with at age 27. Certain cancer drugs, such as Herceptin and doxorubicin, sold as Adriamycin and other brands, can hurt the heart's ability to pump, and lead to heart failure. (AP Photo/Charles Krupa)ORLANDO, Fla. (AP) — Many cancer treatments have a dark side — they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if they take a heart drug as a preventive measure during their cancer care.

Soy might benefit women with pregnancy diabetes

‎11 ‎November ‎2015, ‏‎06:40:55 PMGo to full article
A bushel of soybeans are shown on display in the Monsanto research facility in Creve CoeurBy Kathryn Doyle (Reuters Health) - Consuming soy protein during pregnancy may help women with gestational diabetes control their blood sugar and cholesterol levels, according to a small study. Other research has found that soy can be beneficial in type 2 diabetes, so similar results with the kind of diabetes that first occurs during pregnancy are not surprising, said senior author Zatollah Asemi of Kashan University of Medical Sciences in Iran.

Is It a Cold or Allergies? 6 Telltale Signs

‎11 ‎November ‎2015, ‏‎03:26:09 PMGo to full article
Is It a Cold or Allergies? 6 Telltale SignsPhoto: Pond5By Laurel Leicht for Life by DailyBurn Fall is packed with some of our favorite things -- football (tailgating food!), marathons, all things pumpkin -- but it's also when allergies act up and cold season begins. Problem is, it can be tough to tell if you're coming down with something or if your sinuses are just revolting against...

Former U.S. President Carter responding well to cancer treatment

‎11 ‎November ‎2015, ‏‎12:45:24 AMGo to full article
Former U.S. President Jimmy Carter arrives to speak during an event honoring former U.S. Vice President Walter Mondale in WashingtonFormer U.S. President Jimmy Carter is responding well to cancer treatment and there is no evidence of new malignancy, the Carter Center said on Tuesday. Carter, 91, started treatment in August for melanoma that had spread from his liver to his brain. After recent tests, doctors at Emory University's Winship Cancer Institute gave Carter "good news," the Carter Center said in a statement.

Jury still out on omega-3s for depression

‎10 ‎November ‎2015, ‏‎09:36:51 PMGo to full article
By Kathryn Doyle (Reuters Health) – There is not enough evidence to support over-the-counter omega-3 fatty acid supplements as a treatment for depression, according to a new review. “A number of other reviews investigating the impact of omega-3 fatty acids on depression and depressive disorders have also been conducted, and all of these also find discrepancies between studies, and inconsistencies in findings, and essentially find it difficult to draw convincing conclusions,” said lead author Katherine Appleton of the University of Bournemouth in the U.K. “All reviews also conclude with the need for further evidence,” she said. The new review included 26 randomized controlled trials involving almost 1,500 adults with major depressive disorder in total.

FDA approves Roche's Cotellic for combination skin cancer therapy

‎10 ‎November ‎2015, ‏‎07:01:58 PMGo to full article
Swiss drugmaker Roche's logo is seen at their headquarters in Basel, SwitzerlandThe U.S. Food and Drug Administration on Tuesday approved Swiss drugmaker Roche's Cotellic to be used in combination with the company's Zelboraf drug to treat BRAF V600 mutation-positive advanced melanoma. Roche is counting on the addition of Cotellic to help it revive flagging sales of five-year-old Zelboraf, which dropped 25 percent during the first nine months of 2015 and has been under intense pressure from rivals' drugs as the standard of care moves to combination therapy. The FDA decision, which had been expected this month, applies to advanced melanoma that spreads to other parts of the body or that cannot be removed by surgery, the U.S. regulatory agency said in a statement.

Insulin pumps give kids better control of type 1 diabetes

‎10 ‎November ‎2015, ‏‎05:40:37 PMGo to full article
(This version of the Nov. 9 story corrects spelling of lead author's name in paragraphs 11, 14 and 16.) By Kathryn Doyle (Reuters Health) - As insulin pump use has increased, so has blood sugar control for kids and teens with type 1 diabetes, according to data from Europe and the U.S. But pumps were less common in England and Wales than in Germany or the U.S. “We’ve known that variations in pump use exist (…) but I was surprised that pump therapy wasn’t used more often than what we saw,” said lead author Dr. Jennifer Sherr of the Children's Diabetes Program at the Yale School of Medicine in New Haven. Insulin pumps, which are mounted on the skin and deliver continuous levels of insulin via a catheter, mimic the body’s normal release of insulin, according to the American Diabetes Association.



Insulin pumps give kids better control of type 1 diabetes

‎10 ‎November ‎2015, ‏‎01:11:56 AMGo to full article
By Kathryn Doyle (Reuters Health) – As insulin pump use has increased, so has blood sugar control for kids and teens with type 1 diabetes, according to data from Europe and the U.S. But pumps were less common in England and Wales than in Germany or the U.S. “We’ve known that variations in pump use exist (…) but I was surprised that pump therapy wasn’t used more often than what we saw,” said lead author Dr. Jennifer Sherr of the Children's Diabetes Program at the Yale School of Medicine in New Haven. Insulin pumps, which are mounted on the skin and deliver continuous levels of insulin via a catheter, mimic the body’s normal release of insulin, according to the American Diabetes Association.

Over 230,000 vaccinated in Iraq anti-cholera campaign

‎09 ‎November ‎2015, ‏‎08:01:43 PMGo to full article
An Iraqi girl receives a dose of cholera vaccine at a camp for internally displaced in southwest of the oil hub of Basra on November 1, 2015More than 230,000 people received a first dose of cholera vaccine in a massive campaign to combat an outbreak of the disease in Iraq, the World Health Organisation said Monday. Over 2,500 cases of cholera have been confirmed in Iraq since the outbreak began, causing two confirmed deaths, according to the WHO. Iraqi authorities have blamed the cholera outbreak mostly on the poor quality of water caused by the low level of the Euphrates.

Consuming charred meat may up kidney cancer risk

‎09 ‎November ‎2015, ‏‎06:14:55 PMGo to full article
By Kathryn Doyle (Reuters Health) - People who eat large amounts of meat cooked at high temperature or over an open flame, and are also genetically susceptible, may have a higher risk of kidney cancer, according to a new study. Animal muscle, cooked at high temperatures, produces substances called heterocyclic amines and polycyclic aromatic hydrocarbons, which can cause changes in DNA that may increase cancer risk, according to the National Cancer Institute. Population studies have not found a definite link between cooked meat and cancer in humans, but studies using detailed food questionnaires have found that increased consumption of well done, fried or barbequed meats is tied to an increased risk of cancer of the colon, pancreas and prostate.

Lilly diabetes drug cuts heart failure death, hospitalization: study

‎09 ‎November ‎2015, ‏‎05:46:47 PMGo to full article
By Bill Berkrot ORLANDO (Reuters) - Eli Lilly's new diabetes drug Jardiance significantly cut the risk of heart-related death and hospitalization for heart failure in patients with type 2 diabetes who are at high risk for serious heart problems, according to data from a large study presented on Monday. The 3-year trial of more than 7,000 patients caused a sensation in September, when Lilly and Jardiance partner Boehringer Ingelheim released preliminary data showing the drug cut deaths by 32 percent. Earlier, similar studies of other types of diabetes medicines were undertaken to prove they did not cause heart problems, and a neutral outcome was considered reassuring.

How Depression (Nearly) Killed My Sex Life

‎09 ‎November ‎2015, ‏‎04:10:00 PMGo to full article
I have done battle with depression my whole life. Despair and lethargy have left me hopeless. The first time a doctor suggested medication, she did so with a caveat: The pills -- in my case, Prozac -- might cause me to gain weight and could make it hard to have an orgasm, standard warnings with many antidepressants. "So I'll be fat and...

5 Reasons Why The Future Looks Bright For Humans And Bleak For Cancer

‎09 ‎November ‎2015, ‏‎07:00:19 AMGo to full article
5 Reasons Why The Future Looks Bright For Humans And Bleak For CancerThe history of attempts to understand and control cancer is littered with disappointments and false starts. Many significant advances in research and treatment have been made in recent years, yet the disease remains a leading cause of death in the United States. The slow pace of progress has been frustrating.But scientists and physicians at...

Novo Nordisk diabetes drug fails to help heart failure: study

‎08 ‎November ‎2015, ‏‎11:26:46 PMGo to full article
By Bill Berkrot ORLANDO (Reuters) - The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure, researchers reported at a medical meeting on Sunday. The injectable drug, known chemically as liraglutide, was tested in 300 patients with and without type 2 diabetes who had advanced heart failure and a recent hospitalization. Researchers had hoped that the medicine's effect on blood sugar could mitigate some of the metabolic effects of heart failure.



Hypertension in pregnancy linked to future heart disease

‎06 ‎November ‎2015, ‏‎10:34:28 PMGo to full article
By Lisa Rapaport (Reuters Health) - Women who develop high blood pressure or gestational diabetes during pregnancy may face a greater risk of having these conditions again later in life, a study suggests. To see how these pregnancy complications impacted health later in life, researchers started following more than 22,000 women when they were in their mid-50s, about 27 to 29 years after their first pregnancies had occurred. Women with this problem during pregnancy were also more likely to develop cardiovascular disease.

Infectious Diseases Are More Closely Linked to Sex and Gender Than We Think

‎06 ‎November ‎2015, ‏‎08:53:34 PMGo to full article
Infectious Diseases Are More Closely Linked to Sex and Gender Than We ThinkBy Liliana Losada Brown, PhD, Associate Director, Scientific Programs at SWHRDid you know that more women get sick from salmonella than men [1]? Or that men are more likely to develop staph infections [2]? These are just two examples of the many infectious diseases that impact women and men differently [3]. Even though a new wave of research on...

Moving during childhood linked to poor mental health

‎06 ‎November ‎2015, ‏‎08:32:21 PMGo to full article
By Lisa Rapaport (Reuters Health) - Kids who move many times during childhood may be more likely to experience mental health problems than children who don’t change addresses, an Irish study suggests. After five or more moves, children are more than three times as likely to experience mental health problems, according to an analysis that tracked almost 50,000 youngsters in Northern Ireland from 2001 to 2011. The impact of moving on mental health may also be worse for older children, particularly if they have to leave behind friends and change schools, said lead study author Foteini Tseliou of Queens University in Belfast.

Pregnant women should stay active to avoid depression

‎06 ‎November ‎2015, ‏‎07:33:28 PMGo to full article
Moderate physical activity or standing helps to ward off symptoms of depression in pregnancy, a study suggests.To avoid feeling depressed, putting on too much weight, and contracting gestational diabetes, it is better for pregnant women not to spend too much time sitting, especially in the second trimester, suggest researchers at Warwick University and George Eliott Hospital NHS Trust in the UK.

Prebiotics could help prevent food allergies in the future

‎06 ‎November ‎2015, ‏‎04:06:32 PMGo to full article
Prebiotics are soluble fibers, mainly sugars, which stimulate the growth of bacteria in our gut.Scientists at a French medical research institute have demonstrated in mice that prebiotics reduced the risk of allergy to wheat by improving the immune system's tolerance to allergens. Having previously looked into probiotics, scientists at France's INSERM research institute are now conducting research into prebiotics in the hope of one day stopping the increase in the incidence of food allergies. Prebiotics are soluble fibers, mainly sugars such as cellulose, lactose and insulin, which stimulate the growth of bacteria in the intestine.

Cholera spreads from Iraq to Syria, Kuwait, Bahrain: UNICEF

‎06 ‎November ‎2015, ‏‎12:22:51 PMGo to full article
A patient suffering from cholera rests inside a hospital in BaghdadBy Isabel Coles ERBIL, Iraq (Reuters) - A cholera outbreak in Iraq has spread to neighboring Syria, Kuwait and Bahrain, and risks turning into a region-wide epidemic as millions of pilgrims prepare to visit the country, UNICEF's Iraq director said. The disease, which can lead to death by dehydration and kidney failure within hours if left untreated, was detected west of Baghdad in September and has since infected at least 2,200 people in Iraq and has killed six. "It (the outbreak) already has a regional dynamic and the risk of that can only be increased by people from all over the region coming into Iraq," UNICEF country director, Peter Hawkins, said on Thursday.

Designer cells reverse baby girl's cancer in world first

‎06 ‎November ‎2015, ‏‎10:21:58 AMGo to full article
Designer cells reverse baby girl's cancer in world firstA one-year-old girl in Britain has become the first in the world to be treated with "designer" immune cells genetically engineered to reverse her cancer, doctors said Thursday. Layla Richards was suffering from leukaemia, but was cured after scientists used a new gene-editing technique to manipulate cells to fight the disease at Great Ormond Street Hospital (GOSH) in central London. "As this was the first time that the treatment had been used, we didn't know if or when it would work and so we were over the moon when it did," said Professor Paul Veys, director of bone marrow transplant at GOSH and Layla's head doctor.

Sanofi, Lexicon sign diabetes license and collaboration deal

‎06 ‎November ‎2015, ‏‎08:40:58 AMGo to full article
The Sanofi logo is seen at the company's headquarters in Lyon(Reuters) - Sanofi has agreed to collaborate with Lexicon Pharmaceuticals on Sotagliflozin, a potential oral treatment for people with diabetes, the French drugmaker said on Friday. Lexicon will receive an upfront payment of $300 million under the collaboration and license deal, Sanofi said in a statement. Lexicon could also receive development, regulatory and sales milestone payments of up to $1.4 billion, as well as rising double-digit percentage royalties on net sales of Sotagliflozin. (Reporting by Alan Charlish; Editing by James Regan)

Feast after famine linked to diabetes boom in China

‎05 ‎November ‎2015, ‏‎08:36:45 PMGo to full article
By Lisa Rapaport (Reuters Health) - Rising diabetes rates among middle-aged and elderly adults in China may be tied to their exposure to famine early in life followed by a rapid surge in economic development, a recent study suggests. China experienced a famine between 1959 and 1962. Researchers analyzed data on about 6,900 adults, including roughly 3,800 who experienced famine followed by a different economic status in adulthood.

AstraZeneca cancer drug may not be so fast getting to market

‎05 ‎November ‎2015, ‏‎02:42:30 PMGo to full article
A sign is seen at an AstraZeneca site in MacclesfieldBy Ben Hirschler LONDON (Reuters) - AstraZeneca's keenly awaited cancer immunotherapy drug durvalumab may not get to market as quickly as first hoped but the company said on Thursday it was more confident than ever in its oncology development pipeline. The British drugmaker is running a lung cancer trial known as ATLANTIC that is due to produce results by the end of this year and could, in theory, support a submission seeking accelerated U.S. approval in the first half of 2016. "The landscape has changed because competing products received approval far faster than could have been expected a bit more than a year ago," AstraZeneca Chief Executive Pascal Soriot told reporters in a post-results conference call.


Sanofi, Hanmi seal diabetes licence deal for up to $4.2 billion

‎05 ‎November ‎2015, ‏‎11:56:30 AMGo to full article
The Sanofi logo is seen at the company's headquarters in LyonSanofi signed a licence deal with Hanmi Pharmaceutical to develop experimental, long-acting diabetes treatments, the French drugmaker said on Thursday, in a deal to revive its diabetes division. Korea-based Hanmi will receive an upfront payment of 400 million euros ($434 million) and is eligible for up to 3.5 billion euros in development, registration and sales milestones as well as double-digit royalties on net sales, Sanofi said. In exchange, Sanofi will obtain an exclusive worldwide licence to develop and commercialise a series of therapies.

FDA approves GSK's drug Nucala for severe asthma

‎05 ‎November ‎2015, ‏‎01:40:17 AMGo to full article
The signage for the GlaxoSmithKline building is pictured in LondonGlaxoSmithKline Plc won U.S. regulatory approval for its drug Nucala to treat severe asthma, the Food and Drug Administration said on Wednesday. The drug, Nucala, known also as mepolizumab, was approved for use in combination with other therapies for patients 12 and older who have a history of severe asthma attacks. "This approval offers patients with severe asthma an additional therapy when current treatments cannot maintain adequate control of their asthma," Dr. Badrul Chowdhury, director of the FDA's pulmonary, allergy and rheumatology products division, said in a statement.

Case for testing cancer in blood builds, one study at a time

‎04 ‎November ‎2015, ‏‎09:02:30 PMGo to full article
By Julie Steenhuysen and Ben Hirschler CHICAGO/LONDON (Reuters) - Two new studies published on Wednesday of patients with breast and prostate cancers add to growing evidence that detecting bits of cancer DNA circulating in the blood can guide patient treatment. Enthusiasm is building for "liquid biopsies," which offer a non-invasive alternative to standard tissue biopsies and are expected to be a multibillion-dollar market. At least 38 companies are working on liquid biopsies for cancer, according to analysts at investment bank PiperJaffray, who think the U.S. market alone could eventually reach $29 billion a year.

British cancer drugs fund changes tack: again

‎04 ‎November ‎2015, ‏‎06:19:31 PMGo to full article
A British cancer drugs scheme, slammed as "stupid" by Roche's chief executive two months ago, has undergone another about-turn, with some medicines dropped from coverage now being reinstated. The Cancer Drugs Fund (CDF), which helps patients receive cancer drugs not routinely paid for by the National Health Service (NHS), said on Wednesday that some drugs would remain available after further price negotiations with manufacturers. "It's great news that some drugs that we thought could be lost from the Cancer Drugs Fund are going to remain available for patients – and at a more affordable cost to the NHS," said Paul Workman, chief executive of the Institute of Cancer Research.

Merck KGaA, Pfizer widen development of cancer immunology drug

‎04 ‎November ‎2015, ‏‎03:42:19 PMGo to full article
The Pfizer logo is pictured at their building in the Manhattan borough of New YorkPfizer Inc and Germany's Merck KGaA started the second late-stage drug trial of its avelumab drug against lung cancer, targeting a slice of the growing but crowded cancer immunotherapy field. Avelumab, designed to help the immune system detect and fight tumors, will be tested on newly diagnosed lung-cancer cases in the third and last phase of testing on humans required for regulatory approval, Merck said in a statement on Wednesday. Merck and Pfizer had in April started another phase-three trial with lung-cancer patients whose disease had progressed despite chemotherapy.

Disease victims often shut out of workers' comp system

‎04 ‎November ‎2015, ‏‎12:00:00 PMGo to full article
It's hard enough for injured workers to win comp cases. It can be nearly impossible for sick ones to prevail -- or even file.

U.S. agencies press food companies to prevent disease outbreaks

‎03 ‎November ‎2015, ‏‎10:15:06 PMGo to full article
By Julie Steenhuysen CHICAGO (Reuters) - U.S. regulators want food companies to be more proactive in preventing food-borne diseases, citing new data showing that multistate outbreaks - which involve widely distributed products - cause more than half of all food poisoning deaths, even though they account for just 3 percent of all outbreaks. The call to action comes amid multistate E. coli outbreaks involving 167,427 pounds (76,000 kg) of ground beef made by All American Meats of Omaha, Nebraska, and the closing of 43 Chipotle Mexican Grill Inc restaurants in Washington and Oregon. Just three germs - Salmonella, E. coli, and Listeria - cause 91 percent of outbreaks, contaminate widely distributed foods such as vegetables, beef, chicken and fresh fruits, and end up sickening people in many states, according to a new report by the U.S. Centers for Disease Control and Prevention.

Infant whooping cough infection tied to later epilepsy risk

‎03 ‎November ‎2015, ‏‎08:57:39 PMGo to full article
By Kathryn Doyle (Reuters Health) – Children in Denmark who were diagnosed with pertussis, or “whooping cough,” in early childhood appear to have an increased risk of epilepsy later in childhood, according to a new study. “Although the association we identify may be important on a population level, the individual child admitted to hospital with pertussis will have a very low risk of epilepsy,” said lead author Dr. Morten Olsen of the Aarhus University Hospital in Denmark. Pertussis is an acute respiratory infection common in childhood, affecting about 16 million people per year.

A diabetes test could soon be possible with just a saliva sample and a smartphone

‎03 ‎November ‎2015, ‏‎04:22:54 PMGo to full article
Diabetics currently use needles to monitor their blood sugar levels.A few days ahead of World Diabetes Day (on November 14), information has been revealed about a new device, currently in the development phase, but which could improve early detection of the condition, particularly in disadvantaged communities. Only a smartphone and a saliva sample are needed to find out if you have diabetes. Type 2 diabetes is a disorder which is characterized by difficulty in assimilating, using and storing sugar from food.

The One Thing All Oncologists Agree Can Lower Your Risk Of Cancer

‎03 ‎November ‎2015, ‏‎03:43:07 PMGo to full article
Keeping excess weight off your frame may be the best thing you can do to minimize your risk of certain cancers (aside from not smoking). That's because obesity is increasingly linked to the disease: "It's on track to overtake tobacco as the leading preventable cause of cancer," says Therese Bevers, MD, medical director of the Cancer Prevention...

10 Things I Wish I'd Known About Life After Cancer

‎03 ‎November ‎2015, ‏‎03:29:28 PMGo to full article
10 Things I Wish I'd Known About Life After CancerThere are some things I wish I would have known; things that would have allowed me to see the possibility of the future without how it relates to the past me. These things would have allowed me to let today in, and tomorrow, and the next day. If I could go back to before cancer and tell myself what I didn't know I would feel, this is what I...



Sanofi, BioNTech sign cancer treatment partnership

‎03 ‎November ‎2015, ‏‎08:23:49 AMGo to full article
The Sanofi logo is seen at the company's headquarters in LyonSanofi and BioNTech said they signed a collaboration and license agreement to discover and develop up to five cancer immunotherapies, the companies said in a statement on Tuesday. BioNTech will receive $60 million in upfront and near-term milestone payments and could receive over $300 million in development, regulatory and commercial milestones and other payments per product, the companies said. BioNTech would also be eligible for tiered royalties on net sales up to double digits if the treatments are successfully brought to market, the companies added.

End 'disease' of statelessness in West Africa with better laws, education: U.N

‎03 ‎November ‎2015, ‏‎07:52:25 AMGo to full article
By Kieran Guilbert DAKAR (Thomson Reuters Foundation) - Better laws, concrete data and widespread education are needed to tackle the "disease" of statelessness that blights the lives of more than a million people across West Africa, the United Nations refugee agency (UNHCR) said on Tuesday. With no nationality, stateless people are denied basic human rights and are often unable to work, have access healthcare or send their children to school. "Statelessness is like a disease, you pass it on to your children.

Kids who have puppies or ponies may have lower asthma risk

‎02 ‎November ‎2015, ‏‎11:20:21 PMGo to full article
By Lisa Rapaport (Reuters Health) – Babies exposed to dogs and farm animals may be less likely to develop asthma by the age six, a Swedish study suggests. Dog exposure during infancy was associated with a 13 percent lower risk of asthma in school-age children, while farm animal exposure was linked to a 52 percent risk reduction. While the findings don’t prove that puppies prevent asthma, they do suggest that expectant parents may not need to give away the family pet for fear their baby might develop asthma from being around the dog, said lead study author Tove Fall of Uppsala University in Sweden.

Red Wine Benefits for Those With Diabetes

‎02 ‎November ‎2015, ‏‎06:47:10 PMGo to full article
It can help manage cholesterol and cardiac health. Do you have diabetes? Then you may benefit from drinking a glass of red wine and not even know it.A new study from researchers at Ben-Gurion University of the Negev shows that drinking a glass of red wine every night can help those with type 2 diabetes to not only manage their cholesterol but...

Early exposure to dogs could lower asthma risk

‎02 ‎November ‎2015, ‏‎06:28:42 PMGo to full article
Growing up with a dog might lower asthma risk.Swedish researchers have looked at data on more than one million Swedish children and found that those who grew up with dogs had a 15 percent lower risk of asthma. Building on research that shows a child's risk of asthma drops by half if he or she grows up on a farm, the new study confirmed the "farming effect" and also found that growing up with dogs could be enough to make a difference. The size of the data set allowed the researchers to account for factors such as area of residence or asthma in parents.

Iraq combats cholera with massive vaccination campaign

‎01 ‎November ‎2015, ‏‎05:40:44 PMGo to full article
An internally displaced Iraqi girl receives a dose of cholera vaccine at a camp near Basra on November 1, 2015Iraq is carrying out a major vaccination campaign to combat a cholera outbreak that has infected more than 2,200 people, the health ministry said on Sunday. The campaign, focused on vaccinating people displaced by conflict including the war with the Islamic State group, began Saturday, health minister Adeela Hammoud Hussein said in a statement. The World Health Organisation shipped more than 500,000 doses of oral cholera vaccine to Iraq, enough to treat some 250,000 people.

Bacon fans embrace the hog on cancer report, but futures take fright

‎31 ‎October ‎2015, ‏‎02:15:34 AMGo to full article
Photo illustration of bacon is fried up in a pan in a kitchen in Golden"Give me two pounds of bacon," said Roland Marks, 47, a software engineer, rolling his eyes. "I'll take my chances." It is too early for consumer or retail market data to show what any longer term impacts of the report will be in the United States, or whether shoppers will shun the traditional Christmas ham this year, say industry analysts. The WHO took to Twitter, too, and also issued a statement to emphasize that its International Agency for Research on Cancer (IARC) review "does not ask people to stop eating processed meats," but just indicates that cutting consumption can reduce the risk of colorectal cancer.

U.S. charges Burkina Faso man with fraud over bogus malaria nets

‎30 ‎October ‎2015, ‏‎11:46:27 PMGo to full article
A Burkina Faso man has been criminally charged by U.S. prosecutors in New York over an alleged $12.2 million fraud in which he put millions of people in his home country at risk for malaria by distributing bogus mosquito nets. Malamine Ouedraogo, 33, was accused on Friday by U.S. Attorney Preet Bharara of defrauding the Global Fund to Fight AIDS, Tuberculosis and Malaria in Geneva, Switzerland, and the U.S. Agency for International Development, which both provide financing to promote global health.

5 Ways the Holidays Are Hard on Those With a Chronic Disease (and 10 Ways to Cope)

‎30 ‎October ‎2015, ‏‎10:31:22 PMGo to full article
5 Ways the Holidays Are Hard on Those With a Chronic Disease (and 10 Ways to Cope)Nine years ago, I was diagnosed with type 1 diabetes, a chronic, mostly invisible, autoimmune disease. I utilize an insulin pump, a glucose meter and a continuous glucose monitor to help me control my blood sugar and its effects on me. My blood sugar regulation thrives on predictability and routine, something that is the exact opposite of the...

Novartis, Juno face production hurdles for new blood cancer drugs

‎30 ‎October ‎2015, ‏‎07:32:56 AMGo to full article
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in BaselBy Ransdell Pierson NEW YORK (Reuters) - As drugmakers including Novartis, Juno Therapeutics and Kite Pharma race to launch what may be the most effective treatments ever seen for leukemia and other blood cancers, they are grappling with how to make them widely available in a reliable and cost-efficient way. The new therapies, known as CAR T cells, are made by extracting immune system T cells from an individual patient, altering their DNA to sharpen their ability to spot and kill cancer cells, and infusing them back into the same patient. In some early-stage clinical trials, the treatments eliminated all trace of leukemia and lymphoma in 40 percent to 90 percent of patients who had run out of other options.

WHO says cancer report not a call for people to give up meat

‎29 ‎October ‎2015, ‏‎11:18:22 PMGo to full article
Butcher shops like this one in Godewaersvelde, France, need not fret overmuch: the World Health Organization stressed October 29, 2015 that its recent cancer warning wasn't a call to stop eating meat entirelyThe World Health Organization stressed Thursday that an explosive report this week linking the consumption of processed meat to cancer was not calling for people to stop eating meat altogether. The WHO's International Agency for Research on Cancer (IARC) caused shockwaves Monday when it released a report analysing 800 studies from around the world, concluding that processed meats such as sausages, ham, and hot dogs cause bowel cancer, and red meat "probably" does too. Meat producers slammed the report, with Australia's agriculture minister calling it "a farce", and the North American Meat Institute (NAMI) saying IARC "tortured the data to ensure a specific outcome".

Glowing terms often used for new cancer drugs in health news

‎29 ‎October ‎2015, ‏‎09:43:21 PMGo to full article
By Andrew M. Seaman (Reuters Health) - Health news stories often use overly optimistic terms to describe new cancer drugs, according to a new study. "Each year it seems, you read about a new drug that’s labeled as a 'game changer' or another grandiose word," said senior author Dr. Vinay Prasad, of Oregon Health and Science University in Portland. Searching through Google News, the researchers found 94 stories published over five days that used superlatives like "cure" or "breakthrough" to describe a cancer drug.

Data Visualizations: Racial Gap in Breast Cancer Diagnoses Has Closed

‎29 ‎October ‎2015, ‏‎08:23:53 PMGo to full article
A new study by the American Cancer Society reveals that black and white women are now being diagnosed with breast cancer at the same rate. In the past, the incident rate for black women was lower than for white women. The results were published today in CA: A Cancer Journal for Clinicians. The following visualizations show breast cancer incidence rates by race, the amount of research funding allocated toward breast cancer research in the U.S., incidence and mortality rates associated with breast cancer and breast cancer incidence rates by state.

Popular cholesterol drugs may make flu vaccine less effective

‎29 ‎October ‎2015, ‏‎06:19:03 PMGo to full article
By Lisa Rapaport (Reuters Health) - Millions of people who take statins to lower cholesterol may not get maximum protection from flu vaccines, two new studies suggest. Both studies looked at the effectiveness of flu vaccines in people who were or were not using statins. Taken together, the results connect statins to a dampened immune response to flu vaccines and greater odds of respiratory infections during flu season.

Study: Racial gap in breast cancer diagnoses has closed

‎29 ‎October ‎2015, ‏‎04:04:41 PMGo to full article
NEW YORK (AP) — For decades, breast cancer has been less common in black women than white women, yet killed black women at a higher rate.

FDA expands use of Bristol Myers' cancer drug Yervoy

‎29 ‎October ‎2015, ‏‎12:41:46 AMGo to full article
(Reuters) - The U.S. Food and Drug Administration expanded the use of Bristol-Myers Squibb Co's skin cancer drug, Yervoy, as an additional therapy for patients with late-stage melanoma. This approval extends Yervoy's use to patients with stage III melanoma, who have a high risk of recurrence after surgery, the agency said on Wednesday. Due to the potential for fatal adverse reactions and unusual severe side effects with Yervoy, the drug's label carries a boxed warning - reserved for the most serious of risks.

Breastfeeding pain linked to postpartum depression

‎28 ‎October ‎2015, ‏‎10:25:27 PMGo to full article
By Lisa Rapaport (Reuters Health) - Women who stop breastfeeding due to pain or difficulty getting babies to nurse may be more likely to develop postpartum depression than mothers who stop nursing for other reasons, a small U.K. study suggests. Pediatricians recommend that mothers exclusively breastfeed infants until at least six months of age because it can reduce babies’ risk of ear and respiratory infections, sudden infant death syndrome, allergies, childhood obesity and diabetes. Mothers can benefit too, with longer periods of breastfeeding linked to lower risks of depression, bone deterioration and certain cancers.

8 Famous Female Celebs Who Fought And Won Against Breast Cancer

‎28 ‎October ‎2015, ‏‎07:40:17 PMGo to full article
8 Famous Female Celebs Who Fought And Won Against Breast CancerRemember, you owe it to yourself to get a breast examination done. Read: 6 Easy And Best Ways To Prevent Breast Cancer. Women tend to look at breast cancer from a bird’s eye view, but it is very real and can affect anyone.

California Considers Adding Meat To Cancer-Alert List

‎28 ‎October ‎2015, ‏‎06:15:29 PMGo to full article
California Considers Adding Meat To Cancer-Alert ListCalifornia is examining new World Health Organization findings to determine whether to add red meat and foods like hot dogs, sausages and bacon to a cancer-alert list, setting the stage for a potential battle with the meat industry over warning labels.The inclusion of meat and processed meat on the list could reduce consumer demand, hurting...

As U.S. braces for Syrian refugees, mental health services lag

‎28 ‎October ‎2015, ‏‎01:08:38 PMGo to full article
Migrants wait to board a train at the train station in TovarnikWASHINGTON/DEARBORN, Mich. (Reuters) - More than 20 years after Saddam Hussein's soldiers in Iraq killed his brother in front of him, Ali Alghazally still suffers from night terrors he blames on post-traumatic stress disorder (PTSD), a common problem among refugees often left untreated. As the United States prepares to take in 10,000 or more Syrian refugees in the coming year, social service groups are urging more funding for mental health counseling for cases like Alghazally's, saying it makes resettlement easier. The 48-year-old finally began undergoing psychotherapy last year in Dearborn, a southeastern Michigan city that is home to many Arab-Americans - but not before becoming addicted to anti-anxiety pills and leaving his job as a limousine driver.

Constipation drug extends survival for cancer patients

‎28 ‎October ‎2015, ‏‎02:56:12 AMGo to full article
Opioids like morphine are known to cause severe constipation that often cannot be relieved by traditional laxativesA drug that is given to late-stage cancer patients to help ease the constipation brought on by morphine has been shown to extend their lives, researchers said. Methylnaltrexone, approved by the US Food and Drug Administration in 2008 to treat opioid-induced constipation, could play a role in cancer therapy, said researchers who presented their findings at the meeting of the American Society of Anesthesiologists in San Diego. "Early on, we began to suspect that methylnaltrexone might inhibit cancer growth," said Jonathan Moss, lead author of the study and professor of anesthesia and critical care at the University of Chicago.

Stop Using My Disease to Stop Smoking

‎28 ‎October ‎2015, ‏‎12:08:01 AMGo to full article
Stop Using My Disease to Stop SmokingAs part of its 2015 "Tips From Former Smokers" campaign, the CDC aired an anti-smoking ad that portrayed ostomies as punishment for a bad habit. This turned out to be part of a larger campaign that took advantage of diseases and complications tied to much more than smoking, twisting life-saving and preventative medical care into something akin...

After prostate cancer surgery, blacks have more complications, higher costs

‎27 ‎October ‎2015, ‏‎11:18:19 PMGo to full article
By Lisa Rapaport (Reuters Health) – Older black men who have surgery for prostate cancer may have more complications and pay higher out-of-pocket costs than white men, a U.S. study suggests. Researchers focused on men with localized prostate tumors who would be good candidates for removal of the prostate gland, which is recommended for higher-risk cases.

Cuban kids await 'do or die' cancer drug blocked by US trade ban

‎27 ‎October ‎2015, ‏‎09:43:39 PMGo to full article
Marlene Diaz (L) plays with her granddaughter, seven-year-old cancer patient Noemi Bernardez, at the Cancer Hospital in Havana on October 26, 2015The US embargo on Cuba, which the UN General Assembly formally condemned Tuesday, is not about international politics for Elizabeth Navarro. As far as she's concerned, it's just what keeps her daughter from getting the cancer drug she needs. Navarro's daughter Noemi Bernardez, seven, had a brain tumor removed in September.

Merck profit tops estimates on strong diabetes, cancer drug sales

‎27 ‎October ‎2015, ‏‎04:57:15 PMGo to full article
(Reuters) - Merck & Co Inc on Tuesday reported a higher-than-expected quarterly profit and raised its full-year forecast as demand for its diabetes and cancer drugs increased. Combined sales of diabetes drug Januvia and a related pill called Janumet, which have struggled to grow in the past year, jumped 10 percent to $1.58 billion in the third quarter after only a 1 percent rise in the previous period. Adam Schechter, Merck's head of global human health, said in a conference call with analysts that the treatments for type 2 diabetes got a $100 million boost from stocking by wholesalers.




Weathering the Coming Storm




Price R399.00





Dr. Chuck Missler, an internationally known business executive, outlines our current economic predicament and defensive steps you can take to lessen the impact of the impending economic crisis. As a Bible teacher for over 30 years with a ministry reaching over 40 countries, Chuck shares some key strategies to prepare yourself spiritually and practically.

Is the World facing another major economic upheaval?

What is the best strategy to protect your family in times of economic uncertainty?

The Church has enjoyed a relatively peaceful existence in the West for a few centuries but the with the coming persecution, how do we go about organizing home study and home-church?

Soul Survival – Keeping your “lamp full” during the hard times ahead.

Join Dr. Chuck Missler and Ron Matsen in the Executive Brie fing Room of
The River Lodge, New Zealand, in an intensive summary outlining what lies
ahead and how we can prepare for the coming storm.

Runtime: Approx. 5 hours

© 2012 Koinonia House Inc.

Available in the following formats:



•3 Disks
•5 M4A Files
•1 PDF Notes File
•Color, 16:9, Dolby Digital 2.0 stereo, Region encoding (This DVD will be viewable in other countries WITH the proper DVD player and television set.)



 of the




Dr. Chuck Missler and Ron Matsen


Price R 499.00


There are many diverse anticipations concerning the Coming World Leader, commonly referred to as “The Antichrist.” This study will explore the Biblical descriptions with the specific expectations of the globalists, Islam, the Vatican, Freemasonry, and others.
• Will he be a Nephilim?
• Why is the Vatican openly preparing to receive an “alien” visitor?
• Will he be a resurrection of Nimrod? Is his DNA a factor?
• What are the expectations of transhumanist technologists in this regard?
Clearly, the Bible has much more to illuminate this issue far beyond the popular conceptions; and yet the composite perspective will astonish most. Furthermore, is there a climactic cosmic deception being prepared that, if it were possible, “it would deceive the very elect”? Jesus commanded us, “Be not deceived.” But, how?
How close are these events to our current horizon?
Join Dr. Chuck Missler and Ron Matsen in an intensive summary of some of the Strategic Trends that will impact all of us.
Available in the following formats:

•3 Discs
•6 M4A Files
•1 PDF Notes File
•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region  encoding ( This DVD will be viewable in other countries WITH the proper DVD player and television set.)




Feed image

Featured Video

End the Shame. End the Isolation. End Fistula.







Genetically Modified Food & People.





Go Live           Link


*** New Release ***

 Angels, Volume III:

The Denizens of the Metacosm





Price R 179.00


Angels, Volume III: The Denizens of the Metacosm



by Dr. Chuck Missler



Volumes 1 & 2 of this series explored the finite limits and boundaries of our physical reality. After probing the limits of both the Macrocosm and the Microcosm, we discovered that our reality is but a shadow of larger reality, the Metacosm, a domain of extra-dimensional transfers and other paradoxical phenomena.


Volume 3 explores the contradictory behavior of UFOs and other demonic deceptions characteristic of the End Times. Explore these topics in more detail in either this two-hour briefing, Angels Vol 3: The Denizens of the Metacosm or our six-hour extensive study, Expectations of the Antichrist.



• Are they real?

• Why do UFOs enjoy a military classification higher than our most sensitive weapons systems?

• Why are the events which occurred in Roswell New Mexico still classified after 66 years?

• Why is the Vatican openly preparing to receive an Alien Visitor?

• How should a Christian deal with the occurrences of Alien abductions?

• Jesus admonished us to “Be not deceived.” How?

• How do we prepare for the deception which, “if it were possible, would deceive the very elect”?


Join Dr. Chuck Missler in the Executive Briefing Room of the River Lodge, New Zealand, exploring the misinformation, (and deliberate disinformation) about the various “denizens of the Metacosm” and other insights of the invisible war unfolding on our near horizon.


This briefing pack contains 2 hours of teaching


Available in the following formats



•1 Disc

•2 M4A Files

•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region. This DVD will be viewable in other countries WITH the proper DVD player and television set.)



PRICE  R 159.00


PRICE R 159.00



Price  R 159.00



Price R 159.00













Global Events Disaster Site

Extreme Weather, Epidemic, Terror Attack, Biological Hazard,

Volcano Eruption, Earthquake, Incidents at Sea



"In seasons of severe trial, the Christian has nothing on earth that he can trust to, and is therefore compelled to cast himself on God alone. When no human deliverance can avail, he must simply and entirely trust himself to the providence and care of God. Happy storm that wrecks a man on such a rock as this! O blessed hurricane that drives the soul to God--and God alone!"
- Spurgeon





+27 11 969 0086


















Featured Commentaries

Learn the Bible

 in 24 hours

Old Testament






Joshua and The Twelve Tribes


Ruth and Esther

I and II Samuel

I and II Kings

I and II Chronicles

Ezra & Nehemiah





Song of Songs







Joel and Amos

Jonah, Nahum & Obadiah



The Minor



New Testament







I & II Corinthians




Colossians and Philemon

I and II






I and II Peter

I, II, and III John